{
    "organizations": [],
    "uuid": "60f3a0987729cc9fc4507030c32d3ea4508f9370",
    "author": "",
    "url": "https://www.reuters.com/article/brief-first-patient-enrolled-in-mallinck/brief-first-patient-enrolled-in-mallinckrodt-phase-4-trial-of-h-p-acthar-gel-for-pulmonary-sarcoidosis-idUSASB0C33U",
    "ord_in_thread": 0,
    "title": "BRIEF-First Patient Enrolled In Mallinckrodt Phase 4 Trial Of H.P. Acthar Gel For Pulmonary Sarcoidosis",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 30 (Reuters) - Mallinckrodt Plc:\n* FIRST PATIENT ENROLLED IN MALLINCKRODT PHASE 4 TRIAL OF H.P. ACTHARÂ® GEL (REPOSITORY CORTICOTROPIN INJECTION) FOR PULMONARY SARCOIDOSIS Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-31T00:04:00.000+02:00",
    "crawled": "2018-01-31T00:23:02.003+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "mallinckrodt",
        "plc",
        "first",
        "patient",
        "enrolled",
        "mallinckrodt",
        "phase",
        "trial",
        "gel",
        "repository",
        "corticotropin",
        "injection",
        "pulmonary",
        "sarcoidosis",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}